Bath & Body Works, Inc.
NYSE:BBWISpecialty Retail
+$0.25 today
- Market cap
- $3.76B
- Beta
- 1.39
- P/E (TTM)
- 5.8
- EPS (TTM)
- $3.60
- Dividend yield
- 3.86%
Volume 9.61M
Average 6.12M
BBWI Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Bath & Body Works, Inc.NYSE: BBWI
Deferred Revenue · Q2 FY2026 · quarter ended Aug 2026
Deferred revenue remains negative
Q2 FY2026 deferred revenue was $0, compared with $172M a year earlier. Over 3 fiscal years it compounded at +4.6% a year.
Context
- Deferred revenue amounted to 0.0% of total assets at the end of Q2 FY2026, down 3.6 pp from a year earlier.
- Deferred revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether deferred revenue keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 223M USD
- Year-over-year change
- +13.2%
- 4-year CAGR
- +10.8%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-31 | 223M | +13.2% |
| FY2024 | 2025-02-01 | 197M | -0.5% |
| FY2023 | 2024-02-03 | 198M | +1.5% |
| FY2022 | 2023-01-28 | 195M | +31.8% |
| FY2021 | 2022-01-29 | 148M | — |
Deferred Revenue vs competitors
How BBWI compares with its peers on the latest reported figures
- BBWI's Aug 2026 deferred revenue of $0 is the 6th highest of the 11 companies compared; the peer median is $14.37M.
- Its year-over-year change of -100.0% is the 5th highest of 7, against a peer median of -25.7%.
- Deferred revenue amounts to 0.0% of total assets for BBWI, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Aug 2026 | $298M | — | — | 1.9% | |
| Mar 2026 | $154.53M | -36.3% | — | 1.6% | |
| Mar 2026 | $34.64M | -15.1% | — | 8.6% | |
| Jun 2026 | $32.48M | +37.6% | +24.5% | 1.3% | |
| Mar 2026 | $28.74M | +33.1% | — | 0.4% | |
| Aug 2026 | $0 | -100.0% | +4.6% | 0.0% | |
| Jul 2026 | $0 | -100.0% | +8.9% | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | -100.0% | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding BBWI) | $14.37M | -25.7% | +16.7% | 0.2% | |
Competitors are the stored peer set for BBWI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jan 2022 | FY2022 Jan 2023 | FY2023 Feb 2024 | FY2024 Feb 2025 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.98B | 1.23B | 1.08B | 674M | 953M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 240M | 226M | 224M | 205M | 180M |
| Inventory | 709M | 709M | 710M | 734M | 699M |
| Other Current Assets | 81M | 99M | 97M | 210M | 187M |
| Total Current Assets | 3.01B | 2.27B | 2.12B | 1.82B | 2.02B |
| Property, Plant & Equipment (Net) | 2.03B | 2.24B | 2.28B | 2.08B | 2.07B |
| Goodwill | 628M | 628M | 628M | 628M | 628M |
| Intangible Assets | 165M | 165M | 165M | 165M | 165M |
| Long-term Investments | 126M | 124M | 120M | 26M | 38M |
| Tax Assets | 45M | 37M | 144M | 130M | 112M |
| Other Non-current Assets | 23M | 31M | 15M | 24M | 39M |
| Total Non-current Assets | 3.02B | 3.23B | 3.35B | 3.05B | 3.05B |
| Total Assets | 6.03B | 5.49B | 5.46B | 4.87B | 5.07B |
| Account Payables | 435M | 455M | 380M | 338M | 465M |
| Short-term Debt | 0 | 0 | 0 | 0 | 280M |
| Tax Payables | 73M | 74M | 120M | 117M | 0 |
| Deferred Revenue | 148M | 195M | 198M | 197M | 223M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 1.29B | 1.38B | 1.29B | 1.23B | 1.59B |
| Long-term Debt | 4.85B | 4.86B | 4.39B | 3.88B | 3.61B |
| Deferred Tax Liabilities | 157M | 168M | 147M | 24M | 65M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 253M | 276M | 261M | 233M | 213M |
| Total Non-current Liabilities | 6.25B | 6.32B | 5.8B | 5.02B | 4.76B |
| Total Liabilities | 7.54B | 7.7B | 7.09B | 6.26B | 6.35B |
| Common Stock | 134M | 122M | 120M | 115M | 108M |
| Retained Earnings | (1.8B) | (2.4B) | (1.84B) | (1.58B) | (1.44B) |
| Accumulated OCI | 80M | 78M | 75M | 71M | 74M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1M | 1M | 1M | 2M | 2M |
| Total Equity | (1.52B) | (2.2B) | (1.63B) | (1.38B) | (1.28B) |
| Total Debt | 6.01B | 6.05B | 5.57B | 4.96B | 4.95B |
| Net Debt | 4.03B | 4.82B | 4.49B | 4.29B | 4B |
Bath & Body Works, Inc.
NYSE:BBWI
Intrinsic Alpha fair value
Locked
Current Price
$18.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.